Sun Pharmaceutical Industries Q1FY22 consolidated PAT soars to Rs. 1408.65 Cr
Chemical

Sun Pharmaceutical Industries Q1FY22 consolidated PAT soars to Rs. 1408.65 Cr

It posted net loss of Rs.(2429.81) crores for the period ended June 30, 2020.

  • By ICN Bureau | July 31, 2021

Sun Pharmaceutical Industries has reported total income of Rs.9871.26 crores during the period ended June 30, 2021 as compared to Rs.8633.98 crores during the period ended March 31, 2021.

The company reported total income Rs.7739.04 crores during the period ended June 30, 2020.

The company has posted net profit of Rs.1408.65 crores for the period ended June 30, 2021 as against net profit of Rs.848 crores for the period ended March 31, 2021.

It posted net loss of Rs.(2429.81) crores for the period ended June 30, 2020.

Register Now to Attend NextGen Chemicals & Petrochemicals Summit 2024, 11-12 July 2024, Mumbai

Other Related stories

Startups

Petrochemical

Energy

Digitization